FIGS Bundle
What is the history of FIGS?
FIGS transformed healthcare apparel, turning basic scrubs into stylish, functional wear for medical professionals. Founded in Los Angeles in 2013, the company aimed to enhance the daily work life of healthcare staff with innovative design and quality materials.
The company's core idea was to offer performance-oriented, fitted uniforms, a significant departure from the stagnant designs prevalent in the industry for years. Utilizing a direct-to-consumer e-commerce model, FIGS effectively bypassed traditional retail, building a strong brand and a dedicated customer base.
By 2024, FIGS had secured a 4.28% market share in the Apparel, Footwear & Accessories Industry. This achievement highlights its remarkable growth from its inception. The company's strategic focus on direct-to-consumer sales and product innovation, including items like their popular FIGS PESTEL Analysis, has been key to its success.
What is the FIGS Founding Story?
The journey of FIGS began in 2013, a year marked by the establishment of a company that would redefine medical apparel. Co-founders Heather Hasson and Trina Spear embarked on this venture with a clear vision to elevate the standards of healthcare uniforms. Their combined expertise in fashion and finance laid the groundwork for a brand focused on innovation and quality.
The Genesis of FIGS
Heather Hasson, drawing from her fashion industry background, recognized a significant void in the market for medical professionals. Unlike athletes who benefited from specialized performance wear, healthcare workers were still using outdated and uncomfortable scrubs. Trina Spear, with her Wall Street experience, joined Hasson, bringing crucial financial acumen to transform this identified need into a viable business.
- Founded in 2013 by Heather Hasson and Trina Spear.
- Identified a gap in the market for comfortable, stylish medical apparel.
- Targeted the 150 million healthcare workers globally.
- Chose the name FIGS, referencing historical uses of fig leaves for protection and healing.
The core problem identified by Hasson and Spear was the stagnation within the medical apparel sector. Despite its substantial market size, the industry predominantly offered stiff, ill-fitting scrubs made from basic cotton. This lack of progress contrasted sharply with advancements in other apparel categories. The founders' initial capital came from their personal savings, with Spear notably liquidating her 401(k) to fund the first production run.
FIGS pioneered a direct-to-consumer (DTC) business model within the medical apparel space, a departure from traditional distribution channels. Their early sales strategy involved direct engagement with healthcare professionals, often selling their innovative scrubs from their car in hospital parking lots during shift changes. This approach allowed for immediate feedback and direct connection with their target audience. The company's commitment to innovation and customer-centricity was evident from its inception. The early days saw significant investment, with FIGS securing an initial $2 million seed round in 2013, followed by an additional $3 million in 2014 and 2015, bolstered by angel investors and venture capital. This early financial backing was crucial for scaling their operations and expanding their product line. Understanding the company's financial strategy is key, and a deeper dive into the Revenue Streams & Business Model of FIGS provides further insight into their growth.
FIGS SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of FIGS?
The journey of this medical apparel company began in 2013, marked by a direct-to-consumer approach and a focus on unique product design. This strategy quickly led to significant growth, setting the stage for further expansion and development in the years that followed.
Early Funding and Scaling
In 2017, the company secured $7.5 million in Series A funding, enabling operational scaling and product line expansion. This was swiftly followed by a substantial $65 million Series B round in January 2018, led by Tulco, which significantly boosted its growth trajectory and international ambitions.
Market Penetration and Retail Expansion
By 2018, sales surpassed $100 million, reflecting strong consumer demand for its premium, stylish medical apparel. The company expanded its reach beyond online channels with the opening of its first physical retail store in 2019.
Accelerated Growth and Public Offering
The year 2020 proved pivotal, with revenues more than doubling to $263 million from $110.5 million in 2019, and the company achieving profitability with a net income of $57.9 million. The COVID-19 pandemic further amplified the success of its digital-first model, leading to the introduction of new products like masks and face shields. A major milestone was achieved in May 2021 when the company went public on the NYSE, becoming the first direct-to-consumer healthcare apparel company to do so, with a valuation exceeding $4.5 billion.
Sustained Engagement and Financial Performance
As of Q1 2025, the company boasted an active customer base of 2.7 million, with an average order value of $119. By June 30, 2025, this number grew to 2.74 million active customers, a 4.1% increase year-over-year. For the full fiscal year 2024, net revenues reached $555.6 million, an increase of 1.8% year-over-year. This sustained growth is attributed to its community-driven brand strategy and proprietary fabric technology, which have significantly impacted the previously commoditized medical apparel industry. Understanding the Target Market of FIGS is key to appreciating its growth.
FIGS PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What are the key Milestones in FIGS history?
The journey of this medical apparel company is marked by significant achievements, driven by a commitment to innovation and adaptability in overcoming obstacles. From its inception, the company focused on redefining medical uniforms through advanced materials and a direct-to-consumer approach, quickly establishing a strong brand presence.
| Year | Milestone |
|---|---|
| 2018 | Achieved over $100 million in sales. |
| 2019 | Faced a competitor lawsuit regarding marketing claims. |
| 2020 | Recorded its first profitable year with $263 million in revenue. |
| 2021 | Completed a successful Initial Public Offering (IPO), valuing the company at over $4.5 billion. |
| Q1 2025 | Reported net revenues of $124.9 million, a 5% increase year-over-year. |
| Q2 2025 | Reported net revenues of $152.6 million, a 5.8% increase year-over-year, with net income margin improving to 4.7%. |
A cornerstone of the company's success lies in its dedication to material innovation, exemplified by the development of proprietary fabrics. These advancements have been crucial in creating differentiated products that meet the specific needs of healthcare professionals.
FIONx Fabric Technology
This proprietary fabric offers a combination of antimicrobial properties, wrinkle resistance, stain repellency, and four-way stretch, setting a new benchmark for comfort and performance in medical apparel.
FORMX™ Fabric
Representing a continued commitment to material science, FORMX™ fabric is designed to provide enhanced flexibility and durability, further improving the wearer's experience.
Direct-to-Consumer Model
The company's direct-to-consumer strategy has allowed for greater control over brand messaging and customer relationships, facilitating a deeper understanding of market needs and enabling agile product development.
Product Line Expansion
Beyond traditional scrubs, the company has expanded its offerings to include a wider range of apparel and accessories designed for healthcare professionals, catering to diverse needs within the industry.
Brand Community Building
Emphasis on building a strong brand community through social media engagement and authentic storytelling has fostered significant customer loyalty and brand advocacy.
Data-Driven Design
Utilizing customer feedback and sales data to inform product design and development ensures that offerings remain relevant and highly functional for the target audience.
Despite its successes, the company has navigated challenges such as intense market competition and the complexities of scaling manufacturing while maintaining quality. Recent economic factors, including new tariffs, have also presented hurdles impacting the cost of goods sold.
Market Disruption
Entering a market dominated by established players required a distinct approach to differentiate its brand and product offerings. The company's innovative materials and direct-to-consumer model were key to carving out its niche.
Manufacturing and Supply Chain
Scaling production to meet growing demand while ensuring consistent product quality presented significant operational challenges. Managing manufacturing complexities and potential disruptions is an ongoing focus.
Legal and Competitive Landscape
The company faced legal challenges from competitors, which it perceived as attempts to stifle its growth as a disruptive force. Navigating these disputes required strategic legal and public relations efforts.
Tariffs and Cost Increases
New tariffs imposed on key production regions have led to an anticipated increase in the cost of goods sold. The company is actively working to mitigate these impacts through various strategic adjustments.
Profitability Management
While revenue has grown, maintaining healthy profit margins, especially in the face of rising costs and market pressures, remains a key strategic objective. The company is focused on cost optimization and efficiency improvements.
Maintaining Brand Loyalty
Sustaining strong brand recognition and customer loyalty in a dynamic market is crucial. The company's Marketing Strategy of FIGS, focused on authenticity and community, plays a vital role in this effort.
FIGS Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What is the Timeline of Key Events for FIGS?
The journey of FIGS is a testament to consistent expansion and strategic development, rooted in its initial vision. From its incorporation on December 31, 2012, the company has experienced significant growth, evolving into a prominent name in the medical apparel industry.
| Year | Key Event |
|---|---|
| 2012 | FIGS, Inc. was incorporated on December 31st. |
| 2013 | The company was founded in Los Angeles, California, by Heather Hasson and Trina Spear, and successfully raised a $2 million seed round. |
| 2017 | FIGS secured $7.5 million in Series A funding to fuel its growth. |
| 2018 | The company closed a substantial $65 million Series B funding round and surpassed $100 million in annual sales. |
| 2019 | FIGS opened its first physical retail store, expanding its direct-to-consumer presence. |
| 2020 | The company achieved its first profitable year, reporting revenues of $263 million. |
| 2021 | FIGS completed its Initial Public Offering (IPO) on the NYSE in May, with the company valued at over $4.5 billion. |
| 2024 | Full-year net revenues were reported at $555.6 million as of December 31st. |
| 2025 | Q1 2025 net revenues reached $124.9 million by May 8th, and the company entered the Japanese market in June. |
| 2025 | Q2 2025 net revenues were reported at $152.6 million on August 7th, with plans for a South Korean launch and Latin American expansion in Q3. |
Scaling to $1 Billion Revenue Target
FIGS is strategically focused on reaching $1 billion in revenue. This ambitious goal is supported by operational enhancements, such as the move to a larger distribution center in 2024.
International Market Expansion
With over 80% of global healthcare professionals located outside the U.S., international expansion is a critical growth driver. Recent entry into Japan and planned expansion into South Korea highlight this strategy.
Enhancing Retail and Institutional Presence
The company is expanding its physical retail footprint through 'Community Hubs'. Additionally, the 'TEAMS' program targets healthcare institutions, diversifying revenue streams beyond individual consumer sales.
Product Innovation and Financial Outlook
Continuous product innovation, including new fabric technologies like FORMX™, remains a core focus. For 2025, the company projects low-single-digit net revenue growth and an adjusted EBITDA margin between 8.5% and 9.0%. Navigating macroeconomic factors is managed through strategic inventory and cost controls, reflecting the Competitors Landscape of FIGS.
FIGS Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Competitive Landscape of FIGS Company?
- What is Growth Strategy and Future Prospects of FIGS Company?
- How Does FIGS Company Work?
- What is Sales and Marketing Strategy of FIGS Company?
- What are Mission Vision & Core Values of FIGS Company?
- Who Owns FIGS Company?
- What is Customer Demographics and Target Market of FIGS Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.